Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03037710 · ClinicalTrials.gov registry record
Link-HF: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation
A clinical trial, sponsored by Josef Stehlik.
- Completed
- Registry status
- 100
- Enrollment target
NCT03037710 is a clinical trial that has completed, run by Josef Stehlik. The registered enrollment target is 100 participants.
The verdict
NCT03037710 has completed, sponsored by Josef Stehlik.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This is a multi-center, non-randomized, non-interventional study to evaluate the accuracy of a remote monitoring and analytical platform for prediction of heart failure exacerbation. The platform acquires continuous multivariate vital signs from HF patients using a new ambulatory wearable (attached by an adhesive) multi-sensor device and analyzes the data using a novel machine learning algorithm.
Interventions
- DEVICE HealthPatch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-01-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03037710
The ClinicalTrials.gov registry entry for NCT03037710 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Josef Stehlik, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HealthPatch is the first listed.
NCT03037710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03037710 about?
NCT03037710 is a clinical study titled "Link-HF: Multisensor Non-invasive Telemonitoring System for Prediction of Heart Failure Exacerbation". This is a multi-center, non-randomized, non-interventional study to evaluate the accuracy of a remote monitoring and analytical platform for prediction of heart failure exacerbation. The platform acquires continuous multivariate vital signs from HF patients using a new ambulatory wearable (attached ...
What is the current status of trial NCT03037710?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-06. Estimated completion is 2017-01-26.
What interventions are being tested in trial NCT03037710?
The interventions under investigation include: HealthPatch (DEVICE).
Who is sponsoring clinical trial NCT03037710?
This trial is sponsored by Josef Stehlik, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.